Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1865 1
1910 1
1927 1
1932 1
1941 1
1942 2
1945 1
1946 1
1947 1
1950 1
1954 1
1955 1
1959 1
1960 1
1963 1
1964 1
1965 3
1966 7
1967 2
1968 5
1969 5
1970 5
1971 1
1972 2
1973 2
1974 4
1975 10
1976 9
1977 16
1978 14
1979 18
1980 15
1981 8
1982 16
1983 11
1984 14
1985 23
1986 17
1987 15
1988 21
1989 29
1990 24
1991 25
1992 30
1993 34
1994 26
1995 32
1996 28
1997 28
1998 30
1999 41
2000 41
2001 30
2002 37
2003 30
2004 44
2005 41
2006 37
2007 54
2008 46
2009 58
2010 63
2011 54
2012 53
2013 77
2014 77
2015 82
2016 93
2017 88
2018 101
2019 98
2020 103
2021 115
2022 116
2023 105
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

2,091 results

Results by year

Filters applied: . Clear all
Page 1
Machine Learning in Medicine.
Rajkomar A, Dean J, Kohane I. Rajkomar A, et al. Among authors: dean j. N Engl J Med. 2019 Apr 4;380(14):1347-1358. doi: 10.1056/NEJMra1814259. N Engl J Med. 2019. PMID: 30943338 Review. No abstract available.
A guide to deep learning in healthcare.
Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, Cui C, Corrado G, Thrun S, Dean J. Esteva A, et al. Among authors: dean j. Nat Med. 2019 Jan;25(1):24-29. doi: 10.1038/s41591-018-0316-z. Epub 2019 Jan 7. Nat Med. 2019. PMID: 30617335 Review.
Evidence-Based Practice: A New Dissemination Guide.
Dean J, Gallagher-Ford L, Connor L. Dean J, et al. Worldviews Evid Based Nurs. 2021 Feb;18(1):4-7. doi: 10.1111/wvn.12489. Epub 2021 Feb 3. Worldviews Evid Based Nurs. 2021. PMID: 33534186 No abstract available.
Acute flaccid myelitis: cause, diagnosis, and management.
Murphy OC, Messacar K, Benson L, Bove R, Carpenter JL, Crawford T, Dean J, DeBiasi R, Desai J, Elrick MJ, Farias-Moeller R, Gombolay GY, Greenberg B, Harmelink M, Hong S, Hopkins SE, Oleszek J, Otten C, Sadowsky CL, Schreiner TL, Thakur KT, Van Haren K, Carballo CM, Chong PF, Fall A, Gowda VK, Helfferich J, Kira R, Lim M, Lopez EL, Wells EM, Yeh EA, Pardo CA; AFM working group. Murphy OC, et al. Among authors: dean j. Lancet. 2021 Jan 23;397(10271):334-346. doi: 10.1016/S0140-6736(20)32723-9. Epub 2020 Dec 23. Lancet. 2021. PMID: 33357469 Free PMC article. Review.
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Munir T, Brown JR, O'Brien S, Barrientos JC, Barr PM, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Kipps TJ, Moreno C, Montillo M, Burger JA, Byrd JC, Hillmen P, Dai S, Szoke A, Dean JP, Woyach JA. Munir T, et al. Among authors: dean jp. Am J Hematol. 2019 Dec;94(12):1353-1363. doi: 10.1002/ajh.25638. Epub 2019 Oct 13. Am J Hematol. 2019. PMID: 31512258 Free PMC article. Clinical Trial.
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study.
Wierda WG, Allan JN, Siddiqi T, Kipps TJ, Opat S, Tedeschi A, Badoux XC, Kuss BJ, Jackson S, Moreno C, Jacobs R, Pagel JM, Flinn I, Pak Y, Zhou C, Szafer-Glusman E, Ninomoto J, Dean JP, James DF, Ghia P, Tam CS. Wierda WG, et al. Among authors: dean jp. J Clin Oncol. 2021 Dec 1;39(34):3853-3865. doi: 10.1200/JCO.21.00807. Epub 2021 Oct 7. J Clin Oncol. 2021. PMID: 34618601 Free PMC article. Clinical Trial.
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Moreno C, Greil R, Demirkan F, Tedeschi A, Anz B, Larratt L, Simkovic M, Novak J, Strugov V, Gill D, Gribben JG, Kwei K, Dai S, Hsu E, Dean JP, Flinn IW. Moreno C, et al. Among authors: dean jp. Haematologica. 2022 Sep 1;107(9):2108-2120. doi: 10.3324/haematol.2021.279012. Haematologica. 2022. PMID: 35021599 Free PMC article. Clinical Trial.
2,091 results